MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ANTX — AN2 Therapeutics, Inc. Common Stock
NasdaqAN2 Therapeutics, Inc. Common Stock
$5.71
+0.09(+1.60%)
- O
- 5.64
- H
- 5.99
- L
- 5.51
- V
- 451.28K
⏱️ End-of-day dataAs of Oct 2, 2026
ANTX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $53.49M | $19.94M | $18.00M | $18.22M | $19.98M | $21.35M |
| Other Short Term Investments | $31.80M | $38.06M | $43.92M | $44.70M | $47.08M | $62.27M |
| Other Current Assets | $2.20M | $1.94M | $2.10M | $4.61M | $2.50M | $2.64M |
| Total Current Assets | $87.49M | $59.94M | $64.02M | $67.52M | $69.56M | $86.26M |
| Investments And Advances | 0.00 | $2.01M | $3.22M | $8.30M | $11.48M | $5.02M |
| Total Non Current Assets | 0.00 | $2.01M | $3.22M | $8.30M | $11.78M | $5.83M |
| Total Assets | $87.49M | $61.95M | $67.23M | $75.83M | $81.34M | $92.09M |
| Accounts Payable | $2.62M | $3.02M | $2.23M | $2.11M | $3.07M | $3.32M |
| Accrued Expenses | $1.77M | $2.05M | $2.71M | $2.95M | $4.04M | $4.45M |
| Pensions | 613,000.00 | $2.42M | $1.74M | $1.20M | 529,000.00 | $1.68M |
| Other Current Liabilities | 567,000.00 | $1.23M | 183,000.00 | 717,000.00 | 369,000.00 | 791,000.00 |
| Total Current Liabilities | $5.56M | $8.72M | $6.86M | $6.98M | $8.01M | $10.24M |
| Other Non Current Liabilities | 170,000.00 | 170,000.00 | N/A | N/A | N/A | N/A |
| Total Non Current Liabilities | 170,000.00 | 170,000.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | $5.73M | $8.89M | $6.86M | $6.98M | $8.01M | $10.24M |
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | $-25.10M | $-24.09M | $-23.22M | $-22.29M | $-21.64M | $-20.58M |
| Other Shareholders Equity | -5,000.00 | 57,000.00 | 64,000.00 | 25,000.00 | 48,000.00 | 31,000.00 |
| Total Shareholders Equity | $81.76M | $53.06M | $60.38M | $68.84M | $73.33M | $81.85M |
| Additional Paid In Capital | $33.27M | $29.40M | $29.26M | $29.17M | $28.97M | $28.76M |
| Other Non Current Assets | N/A | N/A | N/A | N/A | 304,000.00 | 804,000.00 |